Guidelines for prostatic biopsies best practice;Recommandations pour la bonne pratique des biopsies prostatiques

Progres en Urologie

Volumn 21, Issue 1, 2011, Pages 18-28

  Ouzzane, A ^a   Coloby, P ^b   Mignard, J P ^c   Allegre, J P ^d   Soulie, M ^e   Rebillard, X ^f   Salomon, L ^g   Villers, A ^a  

^a UNIV LILLE   (France)

^b CENTRE HOSPITALIER RENÉ DUBOS   (France)

^c Clinique Jeanne D'Arc   (France)

^d CENTRE HOSPITALIER DE VALENCE   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f Clinique Beau Soleil   (France)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

Biopsy; Diagnosis; Imaging; Prostatic neoplasm; Staging

Indexed keywords

EID: 78650543845     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2010.07.001     Document Type: Article

References (48)

1. Hodge K.K., McNeal J.E., Terris M.K., Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989, 142:71-74. [discussion 74-5].
2. Lechevallier E. Ponctions biopsies de prostate. Prog Urol 1996, 6:507-518.
3. Giannarini G., Mogorovich A., Valent F., Morelli G., De Maria M., Manassero F., et al. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology 2007, 70:501-505.
4. Bruyere F, d'Arcier BF, Boutin JM, Haillot O. Is urine culture routinely necessary before prostate biopsy? Prostate Cancer Prostatic Dis, 2010 in press, DOI:10.1038.
5. Mignard JP. CdFC, Comité d'évaluation en collaboration avec le Comité d'infectiologie. Gestion préopératoire du risque infectieux. Prog Urol 2004:1049-91, suppl. 1.
6. Lindert K.A., Kabalin J.N., Terris M.K., Bacteremia Bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000, 164:76-80.
7. Briffaux R., Coloby P., Bruyere F., Ouaki F., Pires C., Dore B., et al. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy. BJU Int 2009, 103:1069-1073. [discussion 1073].
8. Bruyere F., Sotto A., Escaravage L., Cariou G., Mignard J.P., Coloby P., et al. Recommandations de bonnes pratiques cliniques l'antibioprophylaxie en chirurgie urologique, par le Comité d'infectiologie de l'association française d'urologie (CIAFU). Prog Urol 2010, 20:101-108.
9. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54.
10. Villers A., Mouton D., Rebillard X., Chautard D., Ruffion A., Staerman F., et al. Conditions de réalisation et schéma de ponctions lors d'une première série de biopsies prostatiques. Prog Urol 2004, 14:144-153.
11. Onik G., Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008, 26:506-510.
12. Moran B.J., Braccioforte M.H., Conterato D.J. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 2006, 176:1376-1381. [discussion 1381].
13. Hergan L., Kashefi C., Parsons J.K. Local anesthetic reduces pain associated with transrectal ultrasound-guided prostate biopsy: a meta-analysis. Urology 2007, 69:520-525.
14. Tiong H.Y., Liew L.C., Samuel M., Consigliere D., Esuvaranathan K. A meta-analysis of local anesthesia for transrectal ultrasound-guided biopsy of the prostate. Prostate Cancer Prostatic Dis 2007, 10:127-136.
15. Long J.A., Manel A., Moalic R., Pellat J.M., Boillot B., Descotes J.L., et al. Utilisation du MEOPA (mélange protoxyde d'azote-oxygène) comme méthode analgésique des biopsies de prostate. Prog Urol 2004, 14:1167-1170.
16. Villers A., Lemaitre L., Haffner J., Puech P. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Curr Opin Urol 2009, 19:274-282.
17. Eichler K., Hempel S., Wilby J., Myers L., Bachmann L.M., Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006, 175:1605-1612.
18. Epstein J.I., Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006, 175:820-834.
19. Scattoni V., Roscigno M., Freschi M., Briganti A., Fantini G.V., Bertini R., et al. Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies. Urology 2005, 66:1043-1047.
20. Gann P.H., Fought A., Deaton R., Catalona W.J., Vonesh E. risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach. J Clin Oncol 2010, 28:1714-1720.
21. Presti J.C. Repeat prostate biopsy - when, where, and how. Urol Oncol 2009, 27:312-314.
22. de la Rosette J.J., Wink M.H., Mamoulakis C., Wondergem N., ten Kate F.J., Zwinderman K., et al. Optimizing prostate cancer detection: 8- versus 12-core biopsy protocol. J Urol 2009, 182:1329-1336.
23. Toi A., Neill M.G., Lockwood G.A., Sweet J.M., Tammsalu L.A., Fleshner N.E. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007, 177:516-520.
24. Hambrock T., Somford D.M., Hoeks C., Bouwense S.A., Huisman H., Yakar D., et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010, 183:527-528. [discussion 528].
25. Lemaitre L., Puech P., Poncelet E., Bouye S., Leroy X., Biserte J., et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 2009, 19:470-480.
26. Puech P., Potiron E., Lemaitre L., Leroy C., Biserte J., Villers A. Dynamic contrast-enhanced MRI evaluation of intraprostatic prostate cancer. Correlation with radical prostatectomy specimens. Urology 2009, 74:1094-1099.
27. Jones J.S., Patel A., Schoenfield L., Rabets J.C., Zippe C.D., Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006, 175:485-488.
28. Pepe P., Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007, 70:1131-1135.
29. Nam R.K., Saskin R., Lee Y., Liu Y., Law C., Klotz L.H., et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010, 183:963-968.
30. Soulie M., Beuzeboc P., Cornud F., Eschwege P., Gaschignard N., Grosclaude P., et al. Cancer de la prostate. Prog Urol 2007, 17:1159-1230.
31. Heidenreich A., Aus G., Bolla M., Joniau S., Matveev V.B., Schmid H.P., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
32. Guichard G., Larre S., Gallina A., Lazar A., Faucon H., Chemama S., et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007, 52:430-435.
33. Ravery V., Dominique S., Panhard X., Toublanc M., Boccon-Gibod L. Boccon-Gibod L. The 20-core prostate biopsy protocol - a new gold standard?. J Urol 2008, 179:504-507.
34. Scattoni V., Raber M., Abdollah F., Roscigno M., Deho F., Angiolilli D., et al. Biopsy schemes with the fewest cores for detecting 95 % of the prostate cancers detected by a 24-core biopsy. Eur Urol 2010, 57:1-8.
35. Scattoni V., Roscigno M., Raber M., Deho F., Maga T., Zanoni M., et al. Initial extended transrectal prostate biopsy - are more prostate cancers detected with 18 cores than with 12 cores?. J Urol 2008, 179:1327-1331. [discussion 1331].
36. Borboroglu P.G., Comer S.W., Riffenburgh R.H., Amling C.L. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000, 163:158-162.
37. Campos-Fernandes J.L., Bastien L., Nicolaiew N., Robert G., Terry S., Vacherot F., et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009, 55:600-606.
38. de la Taille A., Antiphon P., Salomon L., Cherfan M., Porcher R., Hoznek A., et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003, 61:1181-1186.
39. Lane B.R., Zippe C.D., Abouassaly R., Schoenfield L., Magi-Galluzzi C., Jones J.S. Saturation technique does not decrease cancer detection during follow-up after initial prostate biopsy. J Urol 2008, 179:1746-1750. [discussion 1750].
40. Rabets J.C., Jones J.S., Patel A., Zippe C.D. Prostate cancer detection with office-based saturation biopsy in a repeat biopsy population. J Urol 2004, 172:94-97.
41. Stewart C.S., Leibovich B.C., Weaver A.L., Lieber M.M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001, 166:86-91. [discussion 91-2].
42. Walz J., Graefen M., Chun F.K., Erbersdobler A., Haese A., Steuber T., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006, 50:498-505.
43. Ahyai S.A., Isbarn H., Karakiewicz P.I., Chun F.K., Reichert M, Walz J., et al. The presence of prostate cancer on saturation biopsy can be accurately predicted. BJU Int 2010, 105:636-641.
44. Sajadi K.P., Kim T., Terris M.K., Brown J.A., Lewis R.W. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Urology 2007, 70:691-695.
45. Fleshner N., Klotz L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology 2002, 60:93-97.
46. Pinkstaff D.M., Igel T.C., Petrou S.P., Broderick G.A., Wehle M.J., Young P.R. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 2005, 65:735-739.
47. Bott S.R., Henderson A., Halls J.E., Montgomery B.S., Laing R., Langley S.E. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 2006, 68:1037-1041.
48. Satoh T., Matsumoto K., Fujita T., Tabata K., Okusa H., Tsuboi T., et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005, 66:114-118.